Der Ophthalmologe

, Volume 107, Issue 10, pp 937–940

Alkylphosphocholine hemmen die Proliferation und Anhaftung von Linsenepithelzellen

  • R. Liegl
  • M. Kernt
  • K. Obholzer
  • A. Wolf
  • R. Schumann
  • C. Haritoglou
  • A. Kampik
  • K.H. Eibl-Lindner
Originalien

Zusammenfassung

Ziel

Der Nachstar ist die häufigste Komplikation nach erfolgreicher Kataraktchirurgie. 10 Jahre nach Operation benötigen bis zu 42% der Patienten mit Acryllinsen und scharfer Kante eine Nd:YAG-Kapsulotomie. Akkomodative und multifokale Intraokularlinsen weisen zum Teil sogar noch höhere Nachstarraten auf. Eine pharmakologische Prophylaxe mit Alkylphosphocholinen (APC) könnte eine effektive Alternative darstellen.

Methode

Als In-vitro-Modell diente die humane Linsenepithelzelllinie HLE-B3. Nach Inkubation mit APC in unterschiedlichen Konzentrationen (0,01; 0,1 und 1 mM) in Gegenwart von 5% Serum erfolgten der Trypanblau-Ausschlusstest und der Live/Dead-Test. Die Proliferation der Zellen wurde mit dem Tetrazoliumreduktionsassay bestimmt. Die Untersuchung der Anhaftung der Zellen wurde mittels mit Fibronektin und erstmals auch mit Laminin beschichteten Platten durchgeführt.

Ergebnisse

APC können die Proliferation von humanen Linsenepithelzellen in Gegenwart von nur 5% Serum dosisabhängig hemmen. Die Proliferation wurde zu mehr als 60% durch APC-Konzentrationen von 0,1 µM inhibiert, ebenso wie auch die Anhaftung der Linsenepithelzellen um mindestens 50% in Gegenwart von 0,1 µM APC.

Schlussfolgerung

APC hemmen die Proliferation und Anhaftung von humanen Linsenepithelzellen in-vitro. Die Substanz ist topisch applizierbar und eine intraoperative Anwendung zur pharmakologischen Nachstarprophylaxe mit APC grundsätzlich möglich.

Schlüsselwörter

Nachstar Hintere Kapselfibrose Katarakt Alkylphosphocholine Linsenepithelzellen 

Alkylphosphocholines inhibit lens epithelial cell proliferation and attachment

Abstract

Background

Posterior capsule opacification (PCO) is one of the major concerns in modern cataract surgery. Ten years after successful surgery, Nd:YAG capsulotomy is required in up to 42% of patients with an acrylic sharp-edged intraocular lens (IOL). Some accommodative and multifocal IOLs display even higher capsulotomy rates. Pharmacologic prophylaxis with alkylphosphocholines (APCs) could be a novel option in PCO prevention.

Methods

The human lens epithelial cell line HLE-B3 served as an in-vitro model. After incubation with APCs in different concentrations (0.01, 0.1, and 1 mM), the trypan blue exclusion assay and the live/dead test were performed at serum concentrations of only 5%. Cell proliferation was assessed with the MTT test. Evaluation of cell attachment was done with fibronectin- and laminin-coated wells.

Results

APCs can inhibit the proliferation of human lens epithelial cells in the presence of only 5% serum in a dose-dependent manner. Proliferation inhibition of 60% and attachment inhibition of about 50% were reached at concentrations of 0.1 µM.

Conclusion

APCs inhibit proliferation and attachment of human lens epithelial cells in nontoxic concentrations in vitro. The substance can be applied topically, and an intraoperative application for pharmacologic PCO prophylaxis is feasible.

Keywords

After-cataract Posterior capsule opacification Cataract surgery Alkylphosphocholine Lens epithelial cells 

Literatur

  1. 1.
    Awasthi N, Guo S, Wagner BJ (2009) Posterior capsule opacification: a problem reduced but not yet eradicated. Arch Ophthalmol 127:555–562CrossRefPubMedGoogle Scholar
  2. 2.
    Cleary G, Spalton DJ (2008) YAG laser rates decrease, but not as much as expected. Eurotimes 34–35Google Scholar
  3. 3.
    Eibl KH, Banas B, Schoenfeld CL et al (2003) Alkylphosphocholines inhibit proliferation of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 44:3556–3561CrossRefPubMedGoogle Scholar
  4. 4.
    Eibl KH, Banas B, Kook D et al (2004) Alkylphosphocholines: a new therapeutic option in glaucoma filtration surgery. Invest Ophthalmol Vis Sci 45:2619–2624CrossRefPubMedGoogle Scholar
  5. 5.
    Eibl KH, Kook D, Priglinger S et al (2006) Inhibition of human retinal pigment epithelial cell attachment, spreading and migration by alkylphosphocholines. Invest Ophthalmol Vis Sci 47:364–370CrossRefPubMedGoogle Scholar
  6. 6.
    Eibl KH, Lewis GP, Betts K et al (2007) The effect of alkylphosphocholines in intraretinal proliferation initiated by experimental retinal detachment. Invest Ophthalmol Vis Sci 48:1305–1311CrossRefPubMedGoogle Scholar
  7. 7.
    Eibl KH, Schwabe K, Welge-Luessen U et al (2008) The role of alkylphosphocholines in retinal Müller glial cell proliferation. Curr Eye Res 33:385–393CrossRefPubMedGoogle Scholar
  8. 8.
    Eibl KH, Liegl R, Kernt M et al (2009) Alkylphosphocholines as a potential pharmacologic prophylaxis for posterior capsule opacification. J Cataract Refract Surg 35:900–905CrossRefPubMedGoogle Scholar
  9. 9.
    Holweger RR, Marefat B (1997) Intraocular pressure change after neodymium:YAG capsulotomy. J Cataract Refract Surg 23:1115–1121Google Scholar
  10. 10.
    Inan UU, Bozkurt E, Özturk F et al (2006) Effect of diclofenac on prevention of posterior capsule opacification in human eyes. Can J Ophthalmol 41:624–629PubMedGoogle Scholar
  11. 11.
    Javitt JC, Tielsch JM, Canner JK et al (1992) National outcomes of cataract extraction. Increased risk of retinal complications associated with Nd:YAG laser capsulotomy. The cataract patient outcomes team. Ophthalmology 99:1487–1497PubMedGoogle Scholar
  12. 12.
    Kang S, Kim MJ, Park SH, Joo CK (2008) Comparison of clinical results between heparin surface modified hydrophilic and hydrophobic acrylic intraocular lens. Eur J Ophthalmol 18:377–383PubMedGoogle Scholar
  13. 13.
    Kim SY, Kim JH, Choi JS, Joo CK (2007) Comparison of posterior capsule opacification in rabbits receiving either mitomycin-C or destilled water for sealed-capsule irrigation during cataract surgery. Clin Exp Ophthalmol 35:755–758CrossRefGoogle Scholar
  14. 14.
    Leonard R, Hardy J, Tienhoven G van et al (2001) Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J Clin Oncol 21:4150–4159Google Scholar
  15. 15.
    Maloof AJ, Pandey SK, Neilson G, Milverton EJ (2005) Selective death of lens epithelial cells using demineralized warter and Triton X-100 with perfectcapsule sealed capsule irrigation: a histological study in rabbit eyes. Arch Ophthalmol 123:1378–1384CrossRefPubMedGoogle Scholar
  16. 16.
    Mastropasqua L, Toto L, Falconino G et al (2007) Longterm results of 1 CU accomodative intraocular lens: 2-year follow up study. Acta Opthalmol Scand 85:409–414CrossRefGoogle Scholar
  17. 17.
    Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–56CrossRefPubMedGoogle Scholar
  18. 18.
    Newland TJ, Auffarth GU, Wesendahl TA, Apple DJ (1994) Neodymium:YAG laser damage on silicone intraocular lenses. A comparison of lesions on explanted lenses and experimentally produced lesions. J Cataract Refract Surg 20:527–533PubMedGoogle Scholar
  19. 19.
    Nguyen NX, Seitz B, Reese S et al (2005) Accomodation after Nd:YAG capsulotomy in patients with accommodative posterior chamber lens 1CU. Graefes Arch Clin Exp Ophthalmol 243:120–126CrossRefPubMedGoogle Scholar
  20. 20.
    Rabsilber TM, Auffarth GU (2006) Pharmakologische Ansätze zur Prävention der Cataracta secundaria. Klin Monatsbl Augenheilkd 223:559–567CrossRefPubMedGoogle Scholar
  21. 21.
    Rabsilber TM, Limberger IJ, Reuland AJ et al (2007) Long-term results of sealed capsule irrigation using distilled water to prevent posterior capsule opacification: a prospective clinical randomised trial. Br J Ophthalmol 91:912–915CrossRefPubMedGoogle Scholar
  22. 22.
    Schuettauf F, Eibl KH, Thaler S et al (2005) Toxicity study of erucylphosphocholines in a rat model. Curr Eye Res 30:813–820CrossRefPubMedGoogle Scholar
  23. 23.
    Sundar S, Jha TK, Thakur CP et al (2002) Oral miltefoesine for Indian visceral leishmaniasis. N Engl J Med 347:1739–1746CrossRefPubMedGoogle Scholar
  24. 24.
    Van Blitterswijk WJ, Verheij M (2008) Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance and clinical prospects. Curr Pharm Des 14:2061–2074CrossRefGoogle Scholar
  25. 25.
    Vock L, Menapace R, Stifter E et al (2009) Posterior capsule opacification and neodymium: YAG laser capsulotomy rates with a round-edged silicone and a sharp-edged hydrophobic acrylic intraocular lens 10 years after surgery. J Cataract Refract Surg 35:459–465CrossRefPubMedGoogle Scholar
  26. 26.
    Walker TD (2008) Pharmacological attempts to reduce posterior capsule opacification after cataract surgery–a review. Clin Experimental Ophthalmol 36:883–890CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • R. Liegl
    • 1
  • M. Kernt
    • 1
  • K. Obholzer
    • 1
  • A. Wolf
    • 1
  • R. Schumann
    • 1
  • C. Haritoglou
    • 1
  • A. Kampik
    • 1
  • K.H. Eibl-Lindner
    • 1
  1. 1.Augenklinik der LMU München, Campus InnenstadtMünchenDeutschland

Personalised recommendations